•Colorectal cancer is the #2 leading cause of cancer deaths among men and women in the U.S.
•Colorectal cancer accounts for nearly 10% of cancer deaths in the U.S.
•1 in 3 adults age 50-75 are NOT up-to-date with recommended colorectal cancer screening.
•The median age at diagnosis is 69 years old.
•1 in 20 (around 5%) men and women will be diagnosed with colorectal cancer in their lifetime.
•African Americans are more likely to develop colorectal cancer. Screening rates are lower than average in this group so they are more likely to be diagnosed after the cancer has spread to other organs.
•Each year, colorectal cancer treatment costs the U.S. $8.4 billion.
Are you saying that HALO is somehow affiliated with the cure/treatment for CR cancer? If so, where is that drug in the pipeline, which partner is working with HALO, how far away are we from a phase test result. Fezziwig, you're going too crazy with the raw data :)
I think he is simply reminding us how big the market could be for any drug that improved chemo for tumors high in hyaluronic acid. If the MOA is correct, and the data is only half as good as the pancreatic CA ph1, HALO is easily a ten bagger from here. Could that take five years? Yes. Does it seem far fetched? No.